DaVita launches FDA advisory committee prep service

Related tags Clinical research Food and drug administration Pharmaceutical drug Davita clinical research

DaVita Clinical Research will help sponsors prepare for US FDA advisory committee meetings through a new contract offering introduced this week.

The idea is to lead pharmaceutical firms through the process of creating, preparing and rehearsing presentations to agency committees, which are critical steps in its drug approval process.

Mahesh Krishnan, DCR’s VP of clinical research, said: "Professional communicators move pharmaceutical teams toward their goal in a way no other function can -- a lesson I learned from my own experience preparing for an advisory committee meeting."

The new offering brings to an end a busy month for Davita, which began with the launch of a contract biorepository service​ and followed with the expansion of the firm’s drug discovery laboratory in Minneapolis.

Related news

Related products

Small Molecule development – getting it right

Small Molecule development – getting it right

Content provided by Lonza Small Molecules | 20-Jun-2023 | Insight Guide

Small Molecule drug development is something more and more ambitious emerging pharmaceutical companies are taking on from end to end. But this path can...

The Complete Guide to eRegulatory and eSource

The Complete Guide to eRegulatory and eSource

Content provided by Florence Healthcare | 01-Apr-2023 | Insight Guide

Shifting to eRegulatory and eSource workflows is a requirement for clinical trial sites to continue to scale and grow their studies. This guide is designed...

Follow us

Products

View more

Webinars